Open Nav

2018 BIO SPARK Showcase Information To be Announced

Tuesday, October 16, 2018 | 1:00pm - 6:30pm

The BIO SPARK Showcase aims to provide an excellent opportunity for academic researchers in the SPARK network to showcase drug development programs that are ready for partnering or venture funding.

The BIO Investor Forum is historically well attended by the venture arms and business development units of major pharmaceutical companies, smaller specialty pharma/biotech companies looking to add to their pipelines, start-ups, and many early stage venture capital firms, making it the ideal setting for early stage assets from the university setting. Academics interested in partnering will present their programs and also have one-on-one discussions with interested parties. 

2017 BIO SPARK Showcase Presentation Schedule


Spark Affiliate and Program

1:00 PM - 1:10 PM
Welcome from SPARK Translational Research Program, Stanford Medicine
  • Daria Mochly-Rosen, PhD, Director
  • Kevin Grimes, MD, Co-Director
1:10 PM - 1:30 PM
Stanford University- Tranquis Therapeutics
Targeting Myeloid Cell Metabolism for the Treatment of Neurodegenerative Disease
Ed Engleman
1:30 PM - 1:50 PM
National Taiwan University
Development of Potential Therapeutic Agents for Irritable Bowel Syndrome
Ling-Wei Hsin
1:50 PM - 2:10 PM
Kyoto University
Antivirus drug FIT-039
Dr. Masahiko Ajiro
2:10 PM - 2:30 PM
Stanford University
Novel SM for Alzheimer's Disease
Mehrdad Shamloo


2:30 PM - 2:40 PM
2:40 PM - 3:00 PM
Development of Antibody Drug AP001 Against a Novel Tumor Marker Protein AP for Human Cancer Treatment
YuChing Le
3:00 PM - 3:20 PM
Kyoto University
Pain killer without adverse effects
Dr. Masatoshi Hagiwara
3:20 PM - 3:40 PM
Stanford University
Point-of-care diagnostic to measure hyperammonemia in blood
Matthew W. Kanan
3:40 PM - 4:00 PM
SPARK Indiana- Theratome, Inc
Injectable Biologic for Brain Ischemia
Michael Coleman
4:00 PM - 4:10 PM
4:10 PM - 4:30 PM
Kyoto University
Neurogenesis inducer ALGERNON
Dr. Akiko Kobayashi
4:30 PM - 4:50 PM
Stanford University- Hyalos Therapeutics
Stopping Autoimmune Disease by Oral Induction of Treg
Marc Unger
4:50 PM - 5:10 PM
Kyoto University
Apoptosis inducer of cancer cells
Dr. Masayasu Toyomoto
5:10 PM - 5:30 PM
National Taiwan University
Novel NMDA Modulator: RS-D7
Y. Jane Tseng
5:30 PM - 6:30 PM